World Trade Factory™

Bayer Stroke Drug Meets Trial Goal After First Hitting Roadblock

Bayer Stroke Drug Meets Trial Goal After First Hitting Roadblock

Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage clinical study, a boost for the German company as it seeks to counter sales declines from aging blockbuster medicines.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.